Abstract
Endogenous estrogens, namely estradiol, estriol and estrone are essential substances for the sexual determination, growth and reproduction of human beings. Their levels in the human sera are important index in monitoring pregnancy, evaluating menstrual dysfunctions and diagnosing many other diseases. On the other hand, many exoestrogens, including the phytoestrogen such as isoflavones, the synthetic estrogens such as diethylstilbestrol and chemicals of industry origin with suspected estrogenic activity such as bisphenol A and 4-nonylphenol, are drawing increasing attention in recent years. This paper reviews the main immunochemical analytical methods for these important estrogenic substances. The immunizing hapten design and its influence on the specificity of produced antibody were discussed. The typical available immunoassays including enzyme immunoassay (EIA), fluoroimmunoassay (FIA) and chemiluminescence immunoassay (CLIA) for the detection of estrogens were compared with respect to their features (especially dynamic range and limit of detection). The performance of different types of immunosensors with respect to their advantages and disadvantages were evaluated. The future developing trend in this field was also briefly discussed.
Keywords: Endogenous estrogen, Phytoestrogen, Environmental estrogen, Hapten design, Immunoassay, Immunosensor
Current Pharmaceutical Analysis
Title: Immunochemical Analysis of Endogenous and Exogenous Estrogens
Volume: 3 Issue: 1
Author(s): Meiping Zhao, Shuang Zhou, Jin Yan and Lin Li
Affiliation:
Keywords: Endogenous estrogen, Phytoestrogen, Environmental estrogen, Hapten design, Immunoassay, Immunosensor
Abstract: Endogenous estrogens, namely estradiol, estriol and estrone are essential substances for the sexual determination, growth and reproduction of human beings. Their levels in the human sera are important index in monitoring pregnancy, evaluating menstrual dysfunctions and diagnosing many other diseases. On the other hand, many exoestrogens, including the phytoestrogen such as isoflavones, the synthetic estrogens such as diethylstilbestrol and chemicals of industry origin with suspected estrogenic activity such as bisphenol A and 4-nonylphenol, are drawing increasing attention in recent years. This paper reviews the main immunochemical analytical methods for these important estrogenic substances. The immunizing hapten design and its influence on the specificity of produced antibody were discussed. The typical available immunoassays including enzyme immunoassay (EIA), fluoroimmunoassay (FIA) and chemiluminescence immunoassay (CLIA) for the detection of estrogens were compared with respect to their features (especially dynamic range and limit of detection). The performance of different types of immunosensors with respect to their advantages and disadvantages were evaluated. The future developing trend in this field was also briefly discussed.
Export Options
About this article
Cite this article as:
Zhao Meiping, Zhou Shuang, Yan Jin and Li Lin, Immunochemical Analysis of Endogenous and Exogenous Estrogens, Current Pharmaceutical Analysis 2007; 3 (1) . https://dx.doi.org/10.2174/157341207779802377
DOI https://dx.doi.org/10.2174/157341207779802377 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clostridium difficile Infection: Associations with Chemotherapy, Radiation Therapy, and Targeting Therapy Treatments
Current Medicinal Chemistry Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
Current Cancer Drug Targets From Natural Products to Small Molecule Ketone Histone Deacetylase Inhibitors: Development of New Class Specific Agents
Current Pharmaceutical Design From the Sea to Anticancer Therapy
Current Medicinal Chemistry Targeting Sphingosine-1-Phosphate in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future
Current Pharmaceutical Design Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted Therapies
Current Cancer Drug Targets Galectins: Major Signaling Modulators Inside and Outside the Cell
Current Molecular Medicine Clioquinol – A Novel Copper-Dependent and Independent Proteasome Inhibitor
Current Cancer Drug Targets Perspective on Nanoparticle Technology for Biomedical Use
Current Pharmaceutical Design Recent Patents in Autophagy and Immune Response
Recent Patents on Inflammation & Allergy Drug Discovery Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies
Clinical Cancer Drugs Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives
Anti-Cancer Agents in Medicinal Chemistry The Forward Path for Biopharmaceuticals and Biosimilars: Emerging Options in the Selection of Host Cell Systems
Current Biotechnology Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Editorial (Dithiocarbamate complexes with metals in cancer therapy) [Hot Topic Dithiocarbamate complexes with metals in cancer therapy (Guest Editor: Boris Cvek)]
Mini-Reviews in Medicinal Chemistry Overview of Mechanisms of Cancer Stem Cell Drug Resistance
Current Signal Transduction Therapy Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers
Recent Patents on CNS Drug Discovery (Discontinued) Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases
Current Pharmaceutical Design